Skip to content

    Investment Firms in Basel, Switzerland

    Situated within the trinational Upper Rhine region, it is a globally significant hub for life sciences and industrial biotechnology, heavily influenced by the presence of major pharmaceutical corporations. This deep industry expertise anchors a venture capital ecosystem that is particularly specialized in supporting high-growth, late-stage companies in biotech and related sectors. Its strength is further amplified by close collaboration with local universities and research institutes, which provide a steady pipeline of scientific innovation.

    Basel, Switzerland's investment landscape is shaped by Healthcare, with 67% of its 6 investment firms focused on this sector. The most active by portfolio size are Roche Venture Fund, Novartis Pharma AG, and Kickfund.

    Healthcare dominates the investment landscape in Basel, with 67% of investment firms focused on this sector.

    Basel is a particularly strong hub for early-stage investing, with over 100% of investment firms active at the Seed or Pre-Seed stage.

    Last updated: 9 September 2026

    Investment Firms

    6

    Total Investments

    147

    Top Sector

    Healthcare

    Top Stage

    Series A

    Top Investment Sectors in Basel

    The most popular sector focus among Basel investment firms is Healthcare, with 4 investment firms (67%) investing in the space. This is followed by Biotech & Life Sciences (3), Robotics & Automation (1), Hardware & Semiconductors (1), Food & Agriculture (1).

    Investment Stages in Basel

    Basel investment firms are most active at the Series A stage (6 investment firms). This is followed by Seed (6), Series B (4), Series C (4), Series D (3).

    Frequently Asked Questions

    International